Nova Leap Health Stock Forecast for 2023 - 2025 - 2030

Updated on 04/27/2024

Stock Rating
9
Price Target
C$0.45
Consensus
Outperform
Upside
104.55%
Analysts
0
Stock Rating
9
Upside
104.55%
Analysts
0
Price Target
C$0.45

Nova Leap Health Stock Forecast and Price Target

According to experts, who recently provided their 2024 price targets for Nova Leap Health, the average price target is C$0.45, with a high estimate of C$0.45 and a low estimate of C$0.45. That is a potential upside of approximately 104.55% from the last closing price of C$0.22 on April, 2024. If you're considering investing in NLH stock, it's important to look at its competitors too.

C$0.45

104.55% Upside

Buy
Buy

Nova Leap Health Fair Value Forecast for 2023 - 2025 - 2030

Nova Leap Health's Price has seen growth In the last four years, going from C$-0.00 to C$0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach C$0.23 – an increase of 100.00%. For the next seven years, the forecast is forFair Value to grow by 100.00%.

2024 Fair Value Forecast
C$0.23
2025 Fair Value Forecast
C$0.26
2026 Fair Value Forecast
C$0.28
2027 Fair Value Forecast
C$0.31
2028 Fair Value Forecast
C$0.33
2029 Fair Value Forecast
C$0.37
2030 Fair Value Forecast
C$0.40

Nova Leap Health Revenue Forecast for 2023 - 2025 - 2030

Nova Leap Health's Revenue has seen growth In the last three years, going from C$17.31M to C$26.18M – a gain of 51.24% In the following year, 0 experts forecast Nova Leap Health's Revenue will decrease by 11.83%, to C$23.08M. In 2030, professionals predict that Nova Leap Health's Revenue will decrease by 7.86%, to C$24.12M.

2024 Rev Forecast
C$0.02B
2025 Rev Forecast
C$0.02B
2026 Rev Forecast
C$0.02B
2027 Rev Forecast
C$0.03B
2028 Rev Forecast
C$0.02B
2029 Rev Forecast
C$0.02B
2030 Rev Forecast
C$0.02B

Nova Leap Health Dividend per Share Forecast for 2023 - 2025 - 2030

Nova Leap Health Free Cash Flow Forecast for 2023 - 2025 - 2030

Nova Leap Health EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Nova Leap Health's EBITDA has increased by 6650.00%, going from C$20.00k to C$1.35M. In the next year, analysts are expecting an increase in EBITDA, predicting it will reach C$2.00M – an increase of 48.15%. The Nova Leap Health forecast is for EBITDA to reach C$3.77M or grow by 179.31%.

2024 EBITDA Forecast
C$0.00B
2025 EBITDA Forecast
C$0.01B
2026 EBITDA Forecast
C$0.00B
2027 EBITDA Forecast
C$0.00B
2028 EBITDA Forecast
C$0.00B
2029 EBITDA Forecast
C$0.01B
2030 EBITDA Forecast
C$0.00B

Nova Leap Health EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Nova Leap Health's EBIT has grown, increasing from C$-400.00k to C$460.00k – an increase of 215.00%. In the following year, 0 experts forecast that Nova Leap Health's EBIT will decrease by 127.29%, to C$-125.53k. In 2030, professionals predict that Nova Leap Health's EBIT will decrease by 177.54%, to C$-356.69k.

2024 EBIT Forecast
C$-125534.00
2025 EBIT Forecast
C$-189154.63
2026 EBIT Forecast
C$-253700.50
2027 EBIT Forecast
C$-598191.94
2028 EBIT Forecast
C$-365575.04
2029 EBIT Forecast
C$-341934.52
2030 EBIT Forecast
C$-356694.69

Nova Leap Health EPS Price Prediction Forecast for 2023 - 2025 - 2030

Nova Leap Health's EPS has seen growth In the last four years, going from C$-0.00 to C$0.00 – a gain of 100.00% In the next year, analysts believe that EPS will reach C$0.01 – an increase of 100.00%. For the next seven years, the forecast is forEPS to grow by 100.00%.

2024 EPS Forecast
C$0.01
2025 EPS Forecast
C$0.01
2026 EPS Forecast
C$0.01
2027 EPS Forecast
C$0.01
2028 EPS Forecast
C$0.01
2029 EPS Forecast
C$0.01
2030 EPS Forecast
C$0.01